Submissions from 2020
Outcome markers of ART-treated HIV+ patients with early stage Kaposi's sarcoma, Owen Ngalamika, For Yue Tso, Salum Lidenge, Sody Munsaka, Danielle Shea, Charles Wood, and John West
An Update on Screening and Prevention for Breast and Gynecological Cancers in Average and High Risk Individuals, Anahid M. Pahlawanian, Vanessa A. Norris, Amelia M. Jernigan, Brooke Morrell, Mignonne Morrell, Navya Nair, Amber M. Karamanis, Erin M. Dauchy, Michelle M. Loch, and Agustin A. Garcia
Relationships Between Maternal Antibody Responses and Early Childhood Infection With Kaposi Sarcoma-Associated Herpesvirus, Lisa K. Poppe, Chipepo Kankasa, Charles Wood, and John T. West
The Presence of Antibody-Dependent Cell Cytotoxicity-Mediating Antibodies in Kaposi Sarcoma-Associated Herpesvirus-Seropositive Individuals Does Not Correlate with Disease Pathogenesis or Progression, Lisa K. Poppe, Charles Wood, and John T. West
Sunscreen Knowledge Amongst Rheumatologists: Finding the Gap, Ainsley Pratt, John Scheinuk, Dasha Lopez, Christopher J. Mesa, Soham Mahato, Andrew G. Chapple, and Myriam E. Guevara
Cytoreductive Nephrectomy in Patients Presenting With Advanced Disease: Have We Finally Answered the Question?, Daniel D. Shapiro, Mary E. Westerman, Jose A. Karam, and Christopher G. Wood
Clinical Characteristics and Outcomes Based on Race of Hospitalized Patients With COVID-19 in a New Orleans Cohort, Victoria Silver, Andrew G. Chapple, Allison H. Feibus, Jeremy Beckford, Natalie A. Halapin, Delphi Barua, Angellica Gordon, Will Baumgartner, Seth Vignes, Cullen Clark, Sanjay Kamboj, Stephen C. Lim, Scott P. Mackey, Paula S. Seal, Joseph M. Kanter, Caryn Bell, and Meredith E. Clement
Origin of Subsequent Malignant Neoplasms in Patients with History of Testicular Germ Cell Tumor, Eric C. Umbreit, Bilal A. Siddiqui, Michael J. Hwang, Aron Y. Joon, Tapati Maity, Mary E. Westerman, Kelly W. Merriman, Hussam Alhasson, Joma Uthup, Tao Guo, Joseph A. Moore, John F. Ward, Jose A. Karam, Christopher G. Wood, Louis L. Pisters, Miao Zhang, and Shi-Ming Tu
Second-line lenvatinib in patients with recurrent endometrial cancer, Ignace Vergote, Matthew A. Powell, Michael G. Teneriello, David S. Miller, Agustin A. Garcia, Olga N. Mikheeva, Mariusz Bidzinski, Cristina Ligia Cebotaru, Corina E. Dutcus, Min Ren, Tadashi Kadowaki, Yasuhiro Funahashi, and Richard T. Penson
Radical Cystectomy and Perioperative Sexual Function: A Cross-Sectional Analysis, Mary E. Westerman, Andrea Kokorovic, Xin Shelly Wang, Amy Lim, Araceli Garcia-Gonzalez, Mohamed Seif, Run Wang, Ashish M. Kamat, Colin P. Dinney, and Neema Navai
Survival following cytoreductive nephrectomy: a comparison of existing prognostic models, Mary E. Westerman, Daniel D. Shapiro, Nizar M. Tannir, Matthew T. Campbell, Surena F. Matin, Jose A. Karam, and Christopher G. Wood
Neoadjuvant Therapy for Locally Advanced Renal Cell Carcinoma, Mary E. Westerman, Daniel D. Shapiro, Christopher G. Wood, and Jose A. Karam
Gut microbiome associations with breast cancer risk factors and tumor characteristics: a pilot study, Anna H. Wu, Chiuchen Tseng, Cheryl Vigen, Yang Yu, Wendy Cozen, Agustin A. Garcia, and Darcy Spicer
Submissions from 2018
Subgroup-specific dose finding in phase I clinical trials based on time to toxicity allowing adaptive subgroup combination, Andrew G. Chapple and Peter F. Thall